10-K

Company

IGC Pharma, Inc.

Filed

July 15, 2014

Period of Report

March 31, 2014

Accession Number

0001185185-14-001804

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →